5-N-BUTYL-4-{4-[2-(1-H-TETRAZOLE-5-YL)-1-H-PYRROL-1-YL]-PHENYLMETHYL}-2,4-DIHYDRO-2-(2,6-DICHLOROPHENYL)-3-H,1,2,4-TRIAZOL-3-ONE
Compound with spectra: 1 NMR
![5-N-BUTYL-4-{4-[2-(1-H-TETRAZOLE-5-YL)-1-H-PYRROL-1-YL]-PHENYLMETHYL}-2,4-DIHYDRO-2-(2,6-DICHLOROPHENYL)-3-H,1,2,4-TRIAZOL-3-ONE](/api/compound/I47qBPvKhLs.png?ph=true&h=300&w=458 "5-N-BUTYL-4-{4-[2-(1-H-TETRAZOLE-5-YL)-1-H-PYRROL-1-YL]-PHENYLMETHYL}-2,4-DIHYDRO-2-(2,6-DICHLOROPHENYL)-3-H,1,2,4-TRIAZOL-3-ONE")
| SpectraBase Compound ID | I47qBPvKhLs |
|---|---|
| InChI | InChI=1S/C24H22Cl2N8O/c1-2-3-9-21-29-34(22-18(25)6-4-7-19(22)26)24(35)33(21)15-16-10-12-17(13-11-16)32-14-5-8-20(32)23-27-30-31-28-23/h4-8,10-14H,2-3,9,15H2,1H3,(H,27,28,30,31) |
| InChIKey | HFVYQJNHMBNHQV-UHFFFAOYSA-N |
| Mol Weight | 509.4 g/mol |
| Molecular Formula | C24H22Cl2N8O |
| Exact Mass | 508.129363 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(p-Fluorophenyl)-2H-[1,2,4]triazolo-[3,4-a]isoquinolin-3-one
2-(m-Chlorophenyl)-5-methyl-4[4-(p-nitrophenyl)thiazol-2-yl]-2,4-dihydro-3H-1,2,4-triazol-3-one
N-cyclohexyl-6-ethoxy-2,2,4-trimethyl-3,4-dihydro-1(2H)-quinolinecarboxamide
6-ethoxy-2,2,4-trimethyl-N-phenyl-3,4-dihydro-1(2H)-quinolinecarboxamide
2-(p-Chlorophenyl)-2H-[1,2,4]triazolo-[4,3-a]quinolin-1-one
N-(4-methylbenzyl)-4-[(1-(4-methylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
N-(2-chlorobenzyl)-5-(1-(4-fluorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)pentanamide
2-[2'-(4"-phenoxy)pyrimidin-4'-yl)-6,7,8,9-tetrahydro-2H-(1,2,4)-triazolo[4,3-a]azepin-3(5H)-one
[1,3]dioxolo[4,5-g]quinazoline-7-butanamide, N-[(3-chlorophenyl)methyl]-5,6,7,8-tetrahydro-8-oxo-6-thioxo-
3-(1-(4-methylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-N-(2-phenylethyl)propanamide
| Title | Journal or Book | Year |
|---|---|---|
| Structural elucidation of impurities in 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichlorophenyl)-3H-1,2,4-triazol-3-one (Ib), a novel nonpeptide angiotensin AT1 receptor antagonist | Journal of Pharmaceutical and Biomedical Analysis | 2012 |